Pure Global

Pulmonary Hypertension Observational Study - Trial NCT05958901

Access comprehensive clinical trial information for NCT05958901 through Pure Global AI's free database. This phase not specified trial is sponsored by The First Affiliated Hospital of Guangzhou Medical University and is currently Recruiting. The study focuses on Pulmonary Hypertension. Target enrollment is 10000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05958901
Recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT05958901
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Pulmonary Hypertension Observational Study
A Observational Study in Chinese Patients With Pulmonary Hypertension (PH)

Study Focus

Pulmonary Hypertension

pulmonary hypertension

Observational

other

Sponsor & Location

The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, China

Timeline & Enrollment

N/A

Jul 12, 2023

Dec 30, 2027

10000 participants

Primary Outcome

mean pulmonary arterial pressure

Summary

The purpose of this study is to establish the large PH cohort and biological database in
 China, aiming for precision medicine to optimize diagnosis and treatment choices.

ICD-10 Classifications

Primary pulmonary hypertension
Other secondary pulmonary hypertension
Pulmonary heart disease and diseases of pulmonary circulation
Pulmonary heart disease, unspecified
Pulmonary valve disorders

Data Source

ClinicalTrials.gov

NCT05958901

Non-Device Trial